Health CanadaGeneral Alert
KEYTRUDA (pembrolizumab) - Risk of Severe Skin Reactions: Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
Published: March 20, 2017Recall ID: 56351Category: generalCountry: Canada
Safety AlertHealth Canada
Canada
KEYTRUDA (pembrolizumab) - Risk of Severe Skin Reactions: Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
Recalling Firm: Marketed health products
Product Description & Identification
KEYTRUDA (pembrolizumab) - Risk of Severe Skin Reactions: Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
Additional Source Details
| Field | Value |
|---|---|
| N I D | 56351 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/keytruda-pembrolizumab-risk-severe-skin-reactions-stevens-johnson-syndrome-and-toxic |
| Title | KEYTRUDA (pembrolizumab) - Risk of Severe Skin Reactions: Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis |
| Archived | 1 |
| Category | Biologic or vaccine |
| Last updated | 2017-03-20 |
| Organization | Marketed health products |
Check Other Products In Your Household
Free Safety ToolsSafety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:
Overview
- Recalling FirmMarketed health products
Recall Hazard Severity
Official Agency AlertCaution (Class III)
📢 Share Warning
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: Marketed health products - KEYTRUDA (pembrolizumab) - Risk of Severe Skin Reactions: Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Check if your household is affected: https://therecallfile.com/recalls/keytruda-pembrolizumab-risk-of-severe-skin-reactions-stevens-johnson-s/CANADA-56351
Join Alertlist
Get instant email updates whenever critical safety recalls like this are published.
Support The Recall File
Help keep official recall alerts free, accessible, and fast for everyone.
Spread the WordKEYTRUDA (pembrolizumab) - Risk of Severe Skin Reactions: Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis